Showing results (261-270 of 391) with videos related to

Sort By:
Pageof 40
Anticancer Research|May 5, 2005
Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1Carla M L van Herpen, Johan Bussink, Albert J van der Kogel, et al.
British Journal of Cancer|May 28, 2019
Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirationsAnnelieke E C A B Willemsen, Sarah Krausz, Marjolijn J L Ligtenberg, et al.
Molecular Pharmaceutics|May 12, 2017
Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug TransportersPedro Caetano-Pinto, Amer Jamalpoor, Janneke Ham, et al.
Palliative Medicine|September 28, 2024
The focus on life-prolonging anticancer treatment hampers shared decision-making in people with advanced cancer: A qualitative embedded multiple-case studyDaisy Jm Ermers, Maartje J van Geel, Yvonne Engels, et al.
European Urology|September 18, 2012
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinomaAlexander B Stillebroer, Otto C Boerman, Ingrid M E Desar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2015
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer PatientsFabian Birzele, Edgar Voss, Adam Nopora, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2014
Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx®)Marye J Boers-Sonderen, Carla M L van Herpen, Winette T A van der Graaf, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicityEva Peeters, Evelien A J van Genugten, Sandra Heskamp, et al.
Anticancer Research|September 27, 2015
Biological Effects After Discontinuation of VEGFR Inhibitors in Metastatic Renal Cell CancerMarye J Boers-Sonderen, Ingrid M E Desar, Jurgen J Fütterer, et al.
Cancers|April 20, 2019
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)Chantal M Driessen, Janneke C Ham, Maroeska Te Loo, et al.
Pageof 40